{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T17:44:52Z","timestamp":1794246292467,"version":"4.9.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004385","name":"Universiteit Gent","doi-asserted-by":"publisher","award":["BOF\/COR\/2022\/001"],"award-info":[{"award-number":["BOF\/COR\/2022\/001"]}],"id":[{"id":"10.13039\/501100004385","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004385","name":"Universiteit Gent","doi-asserted-by":"publisher","award":["F2023\/IOF-Equip\/099"],"award-info":[{"award-number":["F2023\/IOF-Equip\/099"]}],"id":[{"id":"10.13039\/501100004385","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004385","name":"Universiteit Gent","doi-asserted-by":"publisher","award":["BOF\/STA\/202009\/021"],"award-info":[{"award-number":["BOF\/STA\/202009\/021"]}],"id":[{"id":"10.13039\/501100004385","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004385","name":"Universiteit Gent","doi-asserted-by":"publisher","award":["BOF\/BAS\/2015\/0029\/01"],"award-info":[{"award-number":["BOF\/BAS\/2015\/0029\/01"]}],"id":[{"id":"10.13039\/501100004385","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003441","name":"Universitair Ziekenhuis Gent","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003441","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Research Foundation Flanders","doi-asserted-by":"publisher","award":["G065723N"],"award-info":[{"award-number":["G065723N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jconrel.2025.114365","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T02:17:59Z","timestamp":1761617879000},"page":"114365","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"P2","title":["Cell-specific mRNA delivery via nanobody-functionalized lipid nanoparticles"],"prefix":"10.1016","volume":"388","author":[{"given":"Linglong","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Van Der Weken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Zwaenepoel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina A.","family":"Okkelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Aelvoet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Van Denberghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Gettemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruslan I.","family":"Dmitriev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno G.","family":"De Geest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bert","family":"Devriendt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.114365_bb0005","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2025.114365_bb0010","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines\u2014a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2025.114365_bb0015","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s12272-022-01381-7","article-title":"mRNA vaccines: the most recent clinical applications of synthetic mRNA","volume":"45","author":"Kwon","year":"2022","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.jconrel.2025.114365_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/natrevmats.2017.56","article-title":"Tools for translation: non-viral materials for therapeutic mRNA delivery","volume":"2","author":"Hajj","year":"2017","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2025.114365_bb0025","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature18300","article-title":"Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy","volume":"534","author":"Kranz","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.114365_bb0030","doi-asserted-by":"crossref","first-page":"2000099","DOI":"10.1002\/adtp.202000099","article-title":"Nanoplatforms for mRNA therapeutics","volume":"4","author":"Meng","year":"2021","journal-title":"Adv. Ther."},{"key":"10.1016\/j.jconrel.2025.114365_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119291","article-title":"RNA delivery biomaterials for the treatment of genetic and rare diseases","volume":"217","author":"Zhao","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.114365_bb0040","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.coi.2020.01.008","article-title":"Recent advances in mRNA vaccine technology","volume":"65","author":"Pardi","year":"2020","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jconrel.2025.114365_bb0045","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ymthe.2019.02.012","article-title":"Delivering the messenger: advances in technologies for therapeutic mRNA delivery","volume":"27","author":"Kowalski","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2025.114365_bb0050","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1177\/08971900211009650","article-title":"Review of COVID-19 mRNA vaccines: BNT162b2 and mRNA-1273","volume":"35","author":"Teo","year":"2022","journal-title":"J. Pharm. Pract."},{"key":"10.1016\/j.jconrel.2025.114365_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120586","article-title":"mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability","volume":"601","author":"Schoenmaker","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.114365_bb0060","doi-asserted-by":"crossref","first-page":"4561","DOI":"10.1016\/j.vaccine.2023.06.009","article-title":"Role of anti-polyethylene glycol (PEG) antibodies in the allergic reactions to PEG-containing Covid-19 vaccines: evidence for immunogenicity of PEG","volume":"41","author":"Kozma","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2025.114365_bb0065","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jhep.2022.03.040","article-title":"SARS-CoV-2 vaccination can elicit a CD8 T-cell dominant hepatitis","volume":"77","author":"Boettler","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2025.114365_bb0070","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1056\/NEJMoa2028436","article-title":"Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults","volume":"383","author":"Anderson","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2025.114365_bb0075","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41571-023-00811-9","article-title":"Targeting cancer with mRNA\u2013lipid nanoparticles: key considerations and future prospects","volume":"20","author":"Kon","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2025.114365_bb0080","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2116271119","article-title":"Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis","volume":"119","author":"Qiu","year":"2022","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2025.114365_bb0085","first-page":"718","article-title":"Dual mRNA co-delivery for in situ generation of phagocytosis-enhanced CAR macrophages augments hepatocellular carcinoma immunotherapy","volume":"360","author":"Yang","year":"2023","journal-title":"J. Ophthalmol. Clinics Res."},{"key":"10.1016\/j.jconrel.2025.114365_bb0090","article-title":"Lipid nanoparticle-mediated lymph node\u2013targeting delivery of mRNA cancer vaccine elicits robust CD8+ T cell response","volume":"119","author":"Chen","year":"2022","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2025.114365_bb0095","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1039\/D3NH00145H","article-title":"Selective organ targeting nanoparticles: from design to clinical translation","volume":"8","author":"Li","year":"2023","journal-title":"Nanoscale Horiz."},{"key":"10.1016\/j.jconrel.2025.114365_bb0100","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR\u2013Cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2025.114365_bb0105","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41596-022-00755-x","article-title":"Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery","volume":"18","author":"Wang","year":"2023","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jconrel.2025.114365_bb0110","doi-asserted-by":"crossref","first-page":"13651","DOI":"10.1039\/C7NR04685E","article-title":"A comparison of the human and mouse protein corona profiles of functionalized SiO 2 nanocarriers","volume":"9","author":"Solorio-Rodr\u00edguez","year":"2017","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2025.114365_bb0115","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jconrel.2024.05.036","article-title":"EGFR-targeted ionizable lipid nanoparticles enhance in vivo mRNA delivery to the placenta","volume":"371","author":"Geisler","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114365_bb0120","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3390\/antib9040064","article-title":"Fc-engineering for modulated effector functions\u2014improving antibodies for cancer treatment","volume":"9","author":"Liu","year":"2020","journal-title":"Antibodies"},{"key":"10.1016\/j.jconrel.2025.114365_bb0125","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1146\/annurev-biochem-063011-092449","article-title":"Nanobodies: natural single-domain antibodies","volume":"82","author":"Muyldermans","year":"2013","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.jconrel.2025.114365_bb0130","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1016\/j.apsb.2022.10.020","article-title":"The feasibility of oral targeted drug delivery: gut immune to particulates?","volume":"13","author":"Ren","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2025.114365_bb0135","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ejpb.2017.06.027","article-title":"Neurotensin receptor 1 facilitates intracellular and transepithelial delivery of macromolecules","volume":"119","author":"Bird","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2025.114365_bb0140","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1172\/JCI27821","article-title":"Neonatal Fc receptor for IgG regulates mucosal immune responses to luminal bacteria","volume":"116","author":"Yoshida","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2025.114365_bb0145","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jconrel.2024.01.015","article-title":"Nanoparticles targeting the intestinal fc receptor enhance intestinal cellular trafficking of semaglutide","volume":"366","author":"Pinto","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114365_bb0150","doi-asserted-by":"crossref","first-page":"1192715","DOI":"10.3389\/fimmu.2023.1192715","article-title":"Targeted delivery of oral vaccine antigens to aminopeptidase N protects pigs against pathogenic E. Coli challenge infection","volume":"14","author":"Van der Weken","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.114365_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.753371","article-title":"Antibody-mediated targeting of antigens to intestinal aminopeptidase n elicits gut IgA responses in pigs","volume":"12","author":"Van der Weken","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.114365_bb0160","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jconrel.2015.10.025","article-title":"Devriendt, \u03b2-glucan microparticles targeted to epithelial APN as oral antigen delivery system","volume":"220","author":"Baert","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114365_bb0165","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jconrel.2020.01.033","article-title":"Evaluating single-domain antibodies as carriers for targeted vaccine delivery to the small intestinal epithelium","volume":"321","author":"Bakshi","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114365_bb0170","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.nbt.2020.05.004","article-title":"Nanobody click chemistry for convenient site-specific fluorescent labelling, single step immunocytochemistry and delivery into living cells by photoporation and live cell imaging","volume":"59","author":"Hebbrecht","year":"2020","journal-title":"New Biotechnol."},{"key":"10.1016\/j.jconrel.2025.114365_bb0175","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13567-021-00961-7","article-title":"Porcine small intestinal organoids as a model to explore ETEC\u2013host interactions in the gut","volume":"52","author":"Vermeire","year":"2021","journal-title":"Vet. Res."},{"key":"10.1016\/j.jconrel.2025.114365_bb0180","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3390\/ani12030372","article-title":"Porcine intestinal apical-out organoid model for gut function study","volume":"12","author":"Joo","year":"2022","journal-title":"Animals"},{"key":"10.1016\/j.jconrel.2025.114365_bb0185","doi-asserted-by":"crossref","first-page":"12168","DOI":"10.1021\/acsnano.3c12539","article-title":"Live microscopy of multicellular spheroids with the multimodal near-infrared nanoparticles reveals differences in oxygenation gradients","volume":"18","author":"Debruyne","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.114365_bb0190","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1002\/2211-5463.13882","article-title":"Development of nanobodies against the coat protein of maize chlorotic mottle virus","volume":"14","author":"Njeru","year":"2024","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.jconrel.2025.114365_bb0195","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3390\/ijms20030476","article-title":"Energy-dependent endocytosis is involved in the absorption of indomethacin nanoparticles in the small intestine","volume":"20","author":"Ishii","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2025.114365_bb0200","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1021\/acs.jafc.8b06908","article-title":"Enteroids: promising in vitro models for studies of intestinal physiology and nutrition in farm animals","volume":"67","author":"Yin","year":"2019","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.jconrel.2025.114365_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1242\/jcs.254763","article-title":"Luminescence lifetime imaging of three-dimensional biological objects","volume":"134","author":"Dmitriev","year":"2021","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.jconrel.2025.114365_bb0210","doi-asserted-by":"crossref","first-page":"26685","DOI":"10.1002\/anie.202109749","article-title":"Targetable Conformationally restricted Cyanines enable photon-count-limited applications","volume":"60","author":"Eiring","year":"2021","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2025.114365_bb0215","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3390\/nano10040604","article-title":"Carbon dots for intracellular pH sensing with fluorescence lifetime imaging microscopy","volume":"10","author":"Huang","year":"2020","journal-title":"Nanomaterials"},{"key":"10.1016\/j.jconrel.2025.114365_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2022.101375","article-title":"Achieving dendritic cell subset-specific targeting in vivo by site-directed conjugation of targeting antibodies to nanocarriers","volume":"43","author":"Simon","year":"2022","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2025.114365_bb0225","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01603","article-title":"Nanobodies and nanobody-based human heavy chain antibodies as antitumor therapeutics","volume":"8","author":"Bannas","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.114365_bb0230","doi-asserted-by":"crossref","first-page":"11613","DOI":"10.1073\/pnas.0801763105","article-title":"The effect of particle design on cellular internalization pathways","volume":"105","author":"Gratton","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2025.114365_bb0235","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.nantod.2011.02.003","article-title":"Endocytosis and intracellular transport of nanoparticles: present knowledge and need for future studies","volume":"6","author":"Iversen","year":"2011","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2025.114365_bb0240","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jconrel.2010.01.036","article-title":"Endocytosis of nanomedicines","volume":"145","author":"Sahay","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114365_bb0245","doi-asserted-by":"crossref","first-page":"16220","DOI":"10.1021\/acsnano.0c06336","article-title":"Microfluidic isolation and enrichment of nanoparticles","volume":"14","author":"Xie","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.114365_bb0250","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.3390\/pharmaceutics13122153","article-title":"Versatile and robust method for antibody conjugation to nanoparticles with high targeting efficiency","volume":"13","author":"Van Zundert","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.114365_bb0255","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2314747121","article-title":"Precision treatment of viral pneumonia through macrophage-targeted lipid nanoparticle delivery","volume":"121","author":"Zhao","year":"2024","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2025.114365_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.ab.2019.113491","article-title":"VHH characterization. Recombinant VHHs: Production, characterization and affinity","volume":"589","author":"Chabrol","year":"2020","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jconrel.2025.114365_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121741","article-title":"A robust post-insertion method for the preparation of targeted siRNA LNPs","volume":"620","author":"Swart","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.114365_bb0270","doi-asserted-by":"crossref","first-page":"2409945","DOI":"10.1002\/adma.202409945","article-title":"Conjugation chemistry markedly impacts toxicity and biodistribution of targeted nanoparticles, mediated by complement activation","volume":"37","author":"Zaleski","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.114365_bb0275","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1021\/ja2109745","article-title":"Genetically encoded tetrazine amino acid directs rapid site-specific in vivo bioorthogonal ligation with trans-cyclooctenes","volume":"134","author":"Seitchik","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2025.114365_bb0280","series-title":"Molecular Mechanisms of Apical and Basolateral Sorting in Polarized Epithelial Cells","first-page":"279","author":"Weisz","year":"2016"},{"key":"10.1016\/j.jconrel.2025.114365_bb0285","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1152\/physrev.00001.2003","article-title":"Transcytosis: crossing cellular barriers","volume":"83","author":"Tuma","year":"2003","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jconrel.2025.114365_bb0290","doi-asserted-by":"crossref","first-page":"12386","DOI":"10.1039\/C8NR02393J","article-title":"Influence of protein corona and caveolae-mediated endocytosis on nanoparticle uptake and transcytosis","volume":"10","author":"Ho","year":"2018","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2025.114365_bb0295","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ceb.2008.01.003","article-title":"Regulation of membrane trafficking in polarized epithelial cells","volume":"20","author":"F\u00f6lsch","year":"2008","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.jconrel.2025.114365_bb0300","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.3389\/fimmu.2020.01429","article-title":"High-resolution profiling of innate immune responses by porcine dendritic cell subsets in vitro and in vivo","volume":"11","author":"Auray","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.114365_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.matt.2025.102084","article-title":"Oral nanoparticle therapy for inflammatory bowel disease by Paneth cell regulation and mucus layer remodeling","volume":"8","author":"Qin","year":"2025","journal-title":"Matter"},{"key":"10.1016\/j.jconrel.2025.114365_bb0310","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3390\/vaccines11020490","article-title":"Recent developments in oral delivery of vaccines using nanocarriers","volume":"11","author":"Zafar","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.jconrel.2025.114365_bb0315","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1586\/14760584.7.5.561","article-title":"Vaccination with Dukoral\u00ae against travelers\u2019 diarrhea (ETEC) and cholera","volume":"7","author":"Jelinek","year":"2008","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.jconrel.2025.114365_bb0320","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jconrel.2024.07.052","article-title":"Physicochemical and structural insights into lyophilized mRNA-LNP from lyoprotectant and buffer screenings","volume":"373","author":"Fan","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114365_bb0325","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jconrel.2024.11.010","article-title":"Exploring the impact of commonly used ionizable and pegylated lipids on mRNA-LNPs: a combined in vitro and preclinical perspective","volume":"377","author":"Binici","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114365_bb0330","article-title":"Impact of ionizable lipid type on the pharmacokinetics and biodistribution of mRNA-lipid nanoparticles after intravenous and subcutaneous injection","volume":"113945","author":"Ren","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114365_bb0335","doi-asserted-by":"crossref","first-page":"28311","DOI":"10.1021\/acsnano.4c09677","article-title":"Amplification of protein expression by self-amplifying mRNA delivered in lipid nanoparticles containing a \u03b2-Aminoester Ionizable lipid correlates with reduced innate immune activation","volume":"18","author":"De Lombaerde","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.114365_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113900","article-title":"Strategies for controlling the innate immune activity of conventional and self-amplifying mRNA therapeutics: getting the message across","volume":"176","author":"Minnaert","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.114365_bb0345","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.clinre.2015.11.003","article-title":"Aminopeptidase N (APN\/CD13) as a target molecule for scirrhous gastric cancer","volume":"40","author":"Nohara","year":"2016","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"10.1016\/j.jconrel.2025.114365_bb0350","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1007\/s00432-017-2468-5","article-title":"Efficient targeting of CD13 on cancer cells by the immunotoxin scFv13\u2013ETA\u2032 and the bispecific scFv [13xds16]","volume":"143","author":"Grieger","year":"2017","journal-title":"J. Cancer Res. Clin. Oncol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925009794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925009794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T08:52:18Z","timestamp":1780822338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925009794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":70,"alternative-id":["S0168365925009794"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114365","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cell-specific mRNA delivery via nanobody-functionalized lipid nanoparticles","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114365","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114365"}}